Neurons

The company operates a B2B SaaS and data platform model built on proprietary neuroscience datasets and machine-learning models that predict human responses to visual advertising. Customers upload or integrate creative assets to receive predicted attention heatmaps, behavioural scores and diagnostic metrics, which they then use to iterate adverts prior to launch. This creates value by reducing ineffective creative, improving campaign performance and lowering media waste for advertisers and agencies.

On top of the core platform, the company exposes its predictive capabilities via an API, allowing third-party adtech, analytics and enterprise platforms to embed its attention and impact metrics into their own workflows. It further monetises its accumulated neuromarketing expertise by offering structured online training content, supporting adoption and internal capability-building at client organisations. The business is thus anchored in recurring software and data access, with incremental revenue from integrations and education services.

Neurons Inc. ApS is a Denmark-based neuromarketing and advertising analytics company that uses neuroscience-derived data and AI models to predict how people will visually respond to adverts and other creative assets. Its cloud platform and API estimate attention, memory and engagement outcomes for images and video, enabling rapid pre-testing and optimisation of advertising materials before campaigns go live.

The company primarily serves brand marketing teams, advertising agencies, and related insights and media functions that need systematic, scalable creative testing. It generates revenue through tiered SaaS subscriptions to its platform, paid access to its prediction API for technology and integration partners, and paid online training courses on neuromarketing and use of its tools. Historically it has also conducted neuromarketing research, including via a merger with Sands Research, which strengthened its neuroscience dataset and methods.